0

Close
 
Upcoming Allied Market Research
2023
Diabetic Lancing Devices Market

Diabetic Lancing Devices Market

by Product Type (Standard Lancets, Safety Lancets, Flake Lancets, Fixed Depth Lancet, Others), by Gauge size (17/18g, 21g, 23g, 25g, 28g, 30g, Others), by Penetration Depth (8 mm to 1.0 mm, 1.1 mm to 1.5 mm, 1.6 mm to 2.0 mm, 2.1 mm to 2.5 mm, 2.5 mm to 3.0 mm, Others) and by End user (Research and Development, Hospitals, Clinics, Home Care and Home Diagnostics, Diagnostic Centres and Medical Institutions): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A11422
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Diabetic Lancing Devices Market

Request Now !

Diabetic Lancing Devices Market Outlook - 2027

Diabetic lancing devices are devices used to obtain samples of blood for glucose testing using a lancet. They are widely used in the diagnostic centers, laboratories, hospitals, clinics, and homecare. Their simple design allows self-diagnostics and diabetes monitoring. There are various types of lancets used, which include disposable lancets, flake lancets, stainless steel lancets, blood lancet pen, pull top lancet, twist lancet, universal lancet, suction lancet, pressure activated lancet, push button lancet, side button lancet, fixed depth lancet, and safety lancet. The lancets have special features such as have sharp needle or blade, limited stick exposure, a safety device that protects from unwanted sticks, and disposable, self-testing, and single-use device. These lancets are available in three main categories, which include standard lancets, safety lancets, and specialty lancets. Although the standard lancets are least expensive and employ a simple design, the safety versions of lancets are more popular. Safety lancets are divided into two groups like manual lancets and automatic lancets. Manual devices require removing of the shield and stabbing the patient or pushing a button to deploy a spring activated needle. Automatic lancets activate the needle by pressure or contact with the sample area. It is effective in drawing a sufficient blood sample. It has the advantage perceiving less pain while drawing the blood sample. 

 

COVID-19 Scenario Analysis:

The demand for medical supplies is increasing to take care of infected population. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.

Top impacting factors: market scenario analysis, trends, drivers, impact analysis

Increase in the prevalence of diabetes and rise in the number of patients drive the demand for devices and products to monitor and control diabetes; thereby, leading to rise in adoption of lancets. Wide variety of applications of the devices in the blood testing can help increase the growth of the diabetic lancing devices market. Moreover, increase in the awareness about the blood glucose monitoring device and safety measures to avoid the infectious diseases can also lead to hike in the growth of the market. Rise in healthcare expenditure and easy access for treatment due to increasing number of hospitals also fuel the growth of the diabetes lancing devices market. 

However, rise in the alternative technology for blood testing and high cost of the advanced diabetes management devices are expected to restrain the growth of the diabetic lancing devices market. 

New product launches to flourish the market

In November 2019, Genteel LLC. launched its patented, painless vacuum lancing device. It allows drawing the blood from anywhere on the body without hitting the pain nerves.

In November 2020, Abbott laboratories has launched the FreeStyle Libre System in India. It is a continuous glucose monitoring technology offering the patients the choice to check glucose levels anytime and anywhere, which ultimately improves glucose control. 

Surge in the usage of the diabetic lancing devices

Increase in the incidences of diabetes and rise in awareness regarding blood glucose monitoring and safety measures to avoid these infectious diseases drive the usage of the diabetes lancing devices. Moreover, wide application of the devices in blood testing further fuels the adoption of the diabetic lancing device.   

 

Key benefits of the report:

  • This study presents the analytical depiction of the global diabetic lancing devices industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global diabetic lancing devices market share.
  • The current market is quantitatively analyzed to highlight the global diabetic lancing devices market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global diabetic lancing devices market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the diabetic lancing devices market research report:

  • Which are the leading market players active in the diabetic lancing devices market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps? 

 Diabetic Lancing Devices Market Report Highlights

Aspects Details
By Product Type
  • Standard Lancets
  • Safety Lancets
  • Flake Lancets
  • Fixed Depth Lancet
  • Others
By Gauge size
  • 17/18g
  • 21g
  • 23g
  • 25g
  • 28g
  • 30g
  • Others
By Penetration Depth
  • 8 mm to 1.0 mm
  • 1.1 mm to 1.5 mm
  • 1.6 mm to 2.0 mm
  • 2.1 mm to 2.5 mm
  • 2.5 mm to 3.0 mm
  • Others
By End user
  • Research and Development
  • Hospitals
  • Clinics
  • Home Care and Home Diagnostics
  • Diagnostic Centres and Medical Institutions
By Region
  • North America 
  • Europe 
  • Asia-Pacific 
  • Latin America 
  • The Middle East and Africa 
Key Market Players Greiner Bio-One International GmbH, Bayer AG, Allison Medical Inc., Artsana Group, Abbott Laboratories, Arkray Inc., Eli Lilly and Company, B. Braun Melsungen AG, F. Hoffmann-La Roche AG, Becton Dickinson and Company
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: DIABETIC LANCING DEVICES MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Standard Lancets

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Safety Lancets

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Flake Lancets

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Fixed Depth Lancet

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: DIABETIC LANCING DEVICES MARKET, BY GAUGE SIZE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Gauge Size

    • 5.2. 17/18g

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. 21g

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. 23g

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. 25g

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. 28g

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. 30g

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Others

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

  • CHAPTER 6: DIABETIC LANCING DEVICES MARKET, BY PENETRATION DEPTH

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Penetration Depth

    • 6.2. 8 Mm To 1.0 Mm

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. 1.1 Mm To 1.5 Mm

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. 1.6 Mm To 2.0 Mm

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. 2.1 Mm To 2.5 Mm

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. 2.5 Mm To 3.0 Mm

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

    • 6.7. Others

      • 6.7.1. Key Market Trends, Growth Factors and Opportunities

      • 6.7.2. Market Size and Forecast, By Region

      • 6.7.3. Market Share Analysis, By Country

  • CHAPTER 7: DIABETIC LANCING DEVICES MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Research And Development

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Hospitals

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Clinics

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

    • 7.5. Home Care And Home Diagnostics

      • 7.5.1. Key Market Trends, Growth Factors and Opportunities

      • 7.5.2. Market Size and Forecast, By Region

      • 7.5.3. Market Share Analysis, By Country

    • 7.6. Diagnostic Centres And Medical Institutions

      • 7.6.1. Key Market Trends, Growth Factors and Opportunities

      • 7.6.2. Market Size and Forecast, By Region

      • 7.6.3. Market Share Analysis, By Country

  • CHAPTER 8: DIABETIC LANCING DEVICES MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Product Type

      • 8.2.3. Market Size and Forecast, By Gauge Size

      • 8.2.4. Market Size and Forecast, By Penetration Depth

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Diabetic Lancing Devices Market

        • 8.2.7.1. Market Size and Forecast, By Product Type
        • 8.2.7.2. Market Size and Forecast, By Gauge Size
        • 8.2.7.3. Market Size and Forecast, By Penetration Depth
        • 8.2.7.4. Market Size and Forecast, By End User

      • 8.2.8. Canada Diabetic Lancing Devices Market

        • 8.2.8.1. Market Size and Forecast, By Product Type
        • 8.2.8.2. Market Size and Forecast, By Gauge Size
        • 8.2.8.3. Market Size and Forecast, By Penetration Depth
        • 8.2.8.4. Market Size and Forecast, By End User

      • 8.2.9. Mexico Diabetic Lancing Devices Market

        • 8.2.9.1. Market Size and Forecast, By Product Type
        • 8.2.9.2. Market Size and Forecast, By Gauge Size
        • 8.2.9.3. Market Size and Forecast, By Penetration Depth
        • 8.2.9.4. Market Size and Forecast, By End User

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Product Type

      • 8.3.3. Market Size and Forecast, By Gauge Size

      • 8.3.4. Market Size and Forecast, By Penetration Depth

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Diabetic Lancing Devices Market

        • 8.3.7.1. Market Size and Forecast, By Product Type
        • 8.3.7.2. Market Size and Forecast, By Gauge Size
        • 8.3.7.3. Market Size and Forecast, By Penetration Depth
        • 8.3.7.4. Market Size and Forecast, By End User

      • 8.3.8. Germany Diabetic Lancing Devices Market

        • 8.3.8.1. Market Size and Forecast, By Product Type
        • 8.3.8.2. Market Size and Forecast, By Gauge Size
        • 8.3.8.3. Market Size and Forecast, By Penetration Depth
        • 8.3.8.4. Market Size and Forecast, By End User

      • 8.3.9. Italy Diabetic Lancing Devices Market

        • 8.3.9.1. Market Size and Forecast, By Product Type
        • 8.3.9.2. Market Size and Forecast, By Gauge Size
        • 8.3.9.3. Market Size and Forecast, By Penetration Depth
        • 8.3.9.4. Market Size and Forecast, By End User

      • 8.3.10. Spain Diabetic Lancing Devices Market

        • 8.3.10.1. Market Size and Forecast, By Product Type
        • 8.3.10.2. Market Size and Forecast, By Gauge Size
        • 8.3.10.3. Market Size and Forecast, By Penetration Depth
        • 8.3.10.4. Market Size and Forecast, By End User

      • 8.3.11. UK Diabetic Lancing Devices Market

        • 8.3.11.1. Market Size and Forecast, By Product Type
        • 8.3.11.2. Market Size and Forecast, By Gauge Size
        • 8.3.11.3. Market Size and Forecast, By Penetration Depth
        • 8.3.11.4. Market Size and Forecast, By End User

      • 8.3.12. Russia Diabetic Lancing Devices Market

        • 8.3.12.1. Market Size and Forecast, By Product Type
        • 8.3.12.2. Market Size and Forecast, By Gauge Size
        • 8.3.12.3. Market Size and Forecast, By Penetration Depth
        • 8.3.12.4. Market Size and Forecast, By End User

      • 8.3.13. Rest Of Europe Diabetic Lancing Devices Market

        • 8.3.13.1. Market Size and Forecast, By Product Type
        • 8.3.13.2. Market Size and Forecast, By Gauge Size
        • 8.3.13.3. Market Size and Forecast, By Penetration Depth
        • 8.3.13.4. Market Size and Forecast, By End User

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Product Type

      • 8.4.3. Market Size and Forecast, By Gauge Size

      • 8.4.4. Market Size and Forecast, By Penetration Depth

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Diabetic Lancing Devices Market

        • 8.4.7.1. Market Size and Forecast, By Product Type
        • 8.4.7.2. Market Size and Forecast, By Gauge Size
        • 8.4.7.3. Market Size and Forecast, By Penetration Depth
        • 8.4.7.4. Market Size and Forecast, By End User

      • 8.4.8. Japan Diabetic Lancing Devices Market

        • 8.4.8.1. Market Size and Forecast, By Product Type
        • 8.4.8.2. Market Size and Forecast, By Gauge Size
        • 8.4.8.3. Market Size and Forecast, By Penetration Depth
        • 8.4.8.4. Market Size and Forecast, By End User

      • 8.4.9. India Diabetic Lancing Devices Market

        • 8.4.9.1. Market Size and Forecast, By Product Type
        • 8.4.9.2. Market Size and Forecast, By Gauge Size
        • 8.4.9.3. Market Size and Forecast, By Penetration Depth
        • 8.4.9.4. Market Size and Forecast, By End User

      • 8.4.10. South Korea Diabetic Lancing Devices Market

        • 8.4.10.1. Market Size and Forecast, By Product Type
        • 8.4.10.2. Market Size and Forecast, By Gauge Size
        • 8.4.10.3. Market Size and Forecast, By Penetration Depth
        • 8.4.10.4. Market Size and Forecast, By End User

      • 8.4.11. Australia Diabetic Lancing Devices Market

        • 8.4.11.1. Market Size and Forecast, By Product Type
        • 8.4.11.2. Market Size and Forecast, By Gauge Size
        • 8.4.11.3. Market Size and Forecast, By Penetration Depth
        • 8.4.11.4. Market Size and Forecast, By End User

      • 8.4.12. Thailand Diabetic Lancing Devices Market

        • 8.4.12.1. Market Size and Forecast, By Product Type
        • 8.4.12.2. Market Size and Forecast, By Gauge Size
        • 8.4.12.3. Market Size and Forecast, By Penetration Depth
        • 8.4.12.4. Market Size and Forecast, By End User

      • 8.4.13. Malaysia Diabetic Lancing Devices Market

        • 8.4.13.1. Market Size and Forecast, By Product Type
        • 8.4.13.2. Market Size and Forecast, By Gauge Size
        • 8.4.13.3. Market Size and Forecast, By Penetration Depth
        • 8.4.13.4. Market Size and Forecast, By End User

      • 8.4.14. Indonesia Diabetic Lancing Devices Market

        • 8.4.14.1. Market Size and Forecast, By Product Type
        • 8.4.14.2. Market Size and Forecast, By Gauge Size
        • 8.4.14.3. Market Size and Forecast, By Penetration Depth
        • 8.4.14.4. Market Size and Forecast, By End User

      • 8.4.15. Rest of Asia Pacific Diabetic Lancing Devices Market

        • 8.4.15.1. Market Size and Forecast, By Product Type
        • 8.4.15.2. Market Size and Forecast, By Gauge Size
        • 8.4.15.3. Market Size and Forecast, By Penetration Depth
        • 8.4.15.4. Market Size and Forecast, By End User

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Product Type

      • 8.5.3. Market Size and Forecast, By Gauge Size

      • 8.5.4. Market Size and Forecast, By Penetration Depth

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Diabetic Lancing Devices Market

        • 8.5.7.1. Market Size and Forecast, By Product Type
        • 8.5.7.2. Market Size and Forecast, By Gauge Size
        • 8.5.7.3. Market Size and Forecast, By Penetration Depth
        • 8.5.7.4. Market Size and Forecast, By End User

      • 8.5.8. South Africa Diabetic Lancing Devices Market

        • 8.5.8.1. Market Size and Forecast, By Product Type
        • 8.5.8.2. Market Size and Forecast, By Gauge Size
        • 8.5.8.3. Market Size and Forecast, By Penetration Depth
        • 8.5.8.4. Market Size and Forecast, By End User

      • 8.5.9. Saudi Arabia Diabetic Lancing Devices Market

        • 8.5.9.1. Market Size and Forecast, By Product Type
        • 8.5.9.2. Market Size and Forecast, By Gauge Size
        • 8.5.9.3. Market Size and Forecast, By Penetration Depth
        • 8.5.9.4. Market Size and Forecast, By End User

      • 8.5.10. UAE Diabetic Lancing Devices Market

        • 8.5.10.1. Market Size and Forecast, By Product Type
        • 8.5.10.2. Market Size and Forecast, By Gauge Size
        • 8.5.10.3. Market Size and Forecast, By Penetration Depth
        • 8.5.10.4. Market Size and Forecast, By End User

      • 8.5.11. Argentina Diabetic Lancing Devices Market

        • 8.5.11.1. Market Size and Forecast, By Product Type
        • 8.5.11.2. Market Size and Forecast, By Gauge Size
        • 8.5.11.3. Market Size and Forecast, By Penetration Depth
        • 8.5.11.4. Market Size and Forecast, By End User

      • 8.5.12. Rest of LAMEA Diabetic Lancing Devices Market

        • 8.5.12.1. Market Size and Forecast, By Product Type
        • 8.5.12.2. Market Size and Forecast, By Gauge Size
        • 8.5.12.3. Market Size and Forecast, By Penetration Depth
        • 8.5.12.4. Market Size and Forecast, By End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Abbott Laboratories

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Allison Medical Inc.

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Artsana Group

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Arkray Inc.

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Bayer AG

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Becton Dickinson And Company

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. B. Braun Melsungen AG

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Eli Lilly And Company

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. F. Hoffmann-La Roche AG

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. Greiner Bio-One International GmbH

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL DIABETIC LANCING DEVICES MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL DIABETIC LANCING DEVICES MARKET FOR STANDARD LANCETS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL DIABETIC LANCING DEVICES MARKET FOR SAFETY LANCETS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL DIABETIC LANCING DEVICES MARKET FOR FLAKE LANCETS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL DIABETIC LANCING DEVICES MARKET FOR FIXED DEPTH LANCET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL DIABETIC LANCING DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL DIABETIC LANCING DEVICES MARKET, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 17/18G, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 21G, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 23G, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 25G, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 28G, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 30G, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL DIABETIC LANCING DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL DIABETIC LANCING DEVICES MARKET, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 8 MM TO 1.0 MM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 1.1 MM TO 1.5 MM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 1.6 MM TO 2.0 MM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 2.1 MM TO 2.5 MM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL DIABETIC LANCING DEVICES MARKET FOR 2.5 MM TO 3.0 MM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL DIABETIC LANCING DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL DIABETIC LANCING DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. GLOBAL DIABETIC LANCING DEVICES MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. GLOBAL DIABETIC LANCING DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 25. GLOBAL DIABETIC LANCING DEVICES MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 26. GLOBAL DIABETIC LANCING DEVICES MARKET FOR HOME CARE AND HOME DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 27. GLOBAL DIABETIC LANCING DEVICES MARKET FOR DIAGNOSTIC CENTRES AND MEDICAL INSTITUTIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 28. GLOBAL DIABETIC LANCING DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 29. NORTH AMERICA DIABETIC LANCING DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 30. NORTH AMERICA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 31. NORTH AMERICA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 32. NORTH AMERICA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 33. NORTH AMERICA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. U.S. DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 35. U.S. DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 36. U.S. DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 37. U.S. DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. CANADA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 39. CANADA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 40. CANADA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 41. CANADA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. MEXICO DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. MEXICO DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 44. MEXICO DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 45. MEXICO DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE DIABETIC LANCING DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 47. EUROPE DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 48. EUROPE DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 49. EUROPE DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 50. EUROPE DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. FRANCE DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 52. FRANCE DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 53. FRANCE DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 54. FRANCE DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. GERMANY DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 56. GERMANY DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 57. GERMANY DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 58. GERMANY DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. ITALY DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 60. ITALY DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 61. ITALY DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 62. ITALY DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. SPAIN DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 64. SPAIN DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 65. SPAIN DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 66. SPAIN DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. UK DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 68. UK DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 69. UK DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 70. UK DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. RUSSIA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 72. RUSSIA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 73. RUSSIA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 74. RUSSIA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 75. REST OF EUROPE DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 76. REST OF EUROPE DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 77. REST OF EUROPE DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 78. REST OF EUROPE DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. ASIA-PACIFIC DIABETIC LANCING DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 80. ASIA-PACIFIC DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 81. ASIA-PACIFIC DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 82. ASIA-PACIFIC DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 83. ASIA-PACIFIC DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. CHINA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 85. CHINA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 86. CHINA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 87. CHINA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. JAPAN DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 89. JAPAN DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 90. JAPAN DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 91. JAPAN DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. INDIA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 93. INDIA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 94. INDIA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 95. INDIA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. SOUTH KOREA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 97. SOUTH KOREA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 98. SOUTH KOREA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 99. SOUTH KOREA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. AUSTRALIA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 101. AUSTRALIA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 102. AUSTRALIA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 103. AUSTRALIA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. THAILAND DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 105. THAILAND DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 106. THAILAND DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 107. THAILAND DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. MALAYSIA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 109. MALAYSIA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 110. MALAYSIA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 111. MALAYSIA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 112. INDONESIA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 113. INDONESIA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 114. INDONESIA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 115. INDONESIA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 116. REST OF ASIA PACIFIC DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 117. REST OF ASIA PACIFIC DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 118. REST OF ASIA PACIFIC DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 119. REST OF ASIA PACIFIC DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 120. LAMEA DIABETIC LANCING DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 121. LAMEA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 122. LAMEA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 123. LAMEA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 124. LAMEA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 125. BRAZIL DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 126. BRAZIL DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 127. BRAZIL DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 128. BRAZIL DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 129. SOUTH AFRICA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 130. SOUTH AFRICA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 131. SOUTH AFRICA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 132. SOUTH AFRICA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 133. SAUDI ARABIA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 134. SAUDI ARABIA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 135. SAUDI ARABIA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 136. SAUDI ARABIA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 137. UAE DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 138. UAE DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 139. UAE DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 140. UAE DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 141. ARGENTINA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 142. ARGENTINA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 143. ARGENTINA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 144. ARGENTINA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 145. REST OF LAMEA DIABETIC LANCING DEVICES, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 146. REST OF LAMEA DIABETIC LANCING DEVICES, BY GAUGE SIZE, 2022-2032 ($MILLION)
  • TABLE 147. REST OF LAMEA DIABETIC LANCING DEVICES, BY PENETRATION DEPTH, 2022-2032 ($MILLION)
  • TABLE 148. REST OF LAMEA DIABETIC LANCING DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 149. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 150. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 151. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 152. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 153. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. ALLISON MEDICAL INC.: KEY EXECUTIVES
  • TABLE 155. ALLISON MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 156. ALLISON MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 157. ALLISON MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 158. ALLISON MEDICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 159. ARTSANA GROUP: KEY EXECUTIVES
  • TABLE 160. ARTSANA GROUP: COMPANY SNAPSHOT
  • TABLE 161. ARTSANA GROUP: OPERATING SEGMENTS
  • TABLE 162. ARTSANA GROUP: PRODUCT PORTFOLIO
  • TABLE 163. ARTSANA GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 164. ARKRAY INC.: KEY EXECUTIVES
  • TABLE 165. ARKRAY INC.: COMPANY SNAPSHOT
  • TABLE 166. ARKRAY INC.: OPERATING SEGMENTS
  • TABLE 167. ARKRAY INC.: PRODUCT PORTFOLIO
  • TABLE 168. ARKRAY INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 169. BAYER AG: KEY EXECUTIVES
  • TABLE 170. BAYER AG: COMPANY SNAPSHOT
  • TABLE 171. BAYER AG: OPERATING SEGMENTS
  • TABLE 172. BAYER AG: PRODUCT PORTFOLIO
  • TABLE 173. BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 174. BECTON DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 175. BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 176. BECTON DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 177. BECTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 178. BECTON DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 179. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 180. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 181. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 182. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 183. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 184. ELI LILLY AND COMPANY: KEY EXECUTIVES
  • TABLE 185. ELI LILLY AND COMPANY: COMPANY SNAPSHOT
  • TABLE 186. ELI LILLY AND COMPANY: OPERATING SEGMENTS
  • TABLE 187. ELI LILLY AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 188. ELI LILLY AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 189. F. HOFFMANN-LA ROCHE AG: KEY EXECUTIVES
  • TABLE 190. F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT
  • TABLE 191. F. HOFFMANN-LA ROCHE AG: OPERATING SEGMENTS
  • TABLE 192. F. HOFFMANN-LA ROCHE AG: PRODUCT PORTFOLIO
  • TABLE 193. F. HOFFMANN-LA ROCHE AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 194. GREINER BIO-ONE INTERNATIONAL GMBH: KEY EXECUTIVES
  • TABLE 195. GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY SNAPSHOT
  • TABLE 196. GREINER BIO-ONE INTERNATIONAL GMBH: OPERATING SEGMENTS
  • TABLE 197. GREINER BIO-ONE INTERNATIONAL GMBH: PRODUCT PORTFOLIO
  • TABLE 198. GREINER BIO-ONE INTERNATIONAL GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL DIABETIC LANCING DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL DIABETIC LANCING DEVICES MARKET
  • FIGURE 3. SEGMENTATION DIABETIC LANCING DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN DIABETIC LANCING DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDIABETIC LANCING DEVICES MARKET
  • FIGURE 11. DIABETIC LANCING DEVICES MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. DIABETIC LANCING DEVICES MARKET FOR STANDARD LANCETS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. DIABETIC LANCING DEVICES MARKET FOR SAFETY LANCETS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. DIABETIC LANCING DEVICES MARKET FOR FLAKE LANCETS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. DIABETIC LANCING DEVICES MARKET FOR FIXED DEPTH LANCET, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. DIABETIC LANCING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. DIABETIC LANCING DEVICES MARKET SEGMENTATION, BY BY GAUGE SIZE
  • FIGURE 18. DIABETIC LANCING DEVICES MARKET FOR 17/18G, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. DIABETIC LANCING DEVICES MARKET FOR 21G, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. DIABETIC LANCING DEVICES MARKET FOR 23G, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. DIABETIC LANCING DEVICES MARKET FOR 25G, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. DIABETIC LANCING DEVICES MARKET FOR 28G, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. DIABETIC LANCING DEVICES MARKET FOR 30G, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. DIABETIC LANCING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. DIABETIC LANCING DEVICES MARKET SEGMENTATION, BY BY PENETRATION DEPTH
  • FIGURE 26. DIABETIC LANCING DEVICES MARKET FOR 8 MM TO 1.0 MM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. DIABETIC LANCING DEVICES MARKET FOR 1.1 MM TO 1.5 MM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. DIABETIC LANCING DEVICES MARKET FOR 1.6 MM TO 2.0 MM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. DIABETIC LANCING DEVICES MARKET FOR 2.1 MM TO 2.5 MM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. DIABETIC LANCING DEVICES MARKET FOR 2.5 MM TO 3.0 MM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. DIABETIC LANCING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. DIABETIC LANCING DEVICES MARKET SEGMENTATION, BY END USER
  • FIGURE 33. DIABETIC LANCING DEVICES MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 34. DIABETIC LANCING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 35. DIABETIC LANCING DEVICES MARKET FOR CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 36. DIABETIC LANCING DEVICES MARKET FOR HOME CARE AND HOME DIAGNOSTICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 37. DIABETIC LANCING DEVICES MARKET FOR DIAGNOSTIC CENTRES AND MEDICAL INSTITUTIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 38. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 41. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 42. COMPETITIVE DASHBOARD
  • FIGURE 43. COMPETITIVE HEATMAP: DIABETIC LANCING DEVICES MARKET
  • FIGURE 44. Top player positioning, 2022
  • FIGURE 45. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. ALLISON MEDICAL INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. ALLISON MEDICAL INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. ALLISON MEDICAL INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. ARTSANA GROUP: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. ARTSANA GROUP: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. ARTSANA GROUP: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. ARKRAY INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. ARKRAY INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. ARKRAY INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. BAYER AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. BAYER AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. BAYER AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. BECTON DICKINSON AND COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. BECTON DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. BECTON DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 66. ELI LILLY AND COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. ELI LILLY AND COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 68. ELI LILLY AND COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 69. F. HOFFMANN-LA ROCHE AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 70. F. HOFFMANN-LA ROCHE AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 71. F. HOFFMANN-LA ROCHE AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 72. GREINER BIO-ONE INTERNATIONAL GMBH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 73. GREINER BIO-ONE INTERNATIONAL GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 74. GREINER BIO-ONE INTERNATIONAL GMBH: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Diabetic Lancing Devices Market

Start reading.
This Report and over 68,113+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers